.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Julphar
Queensland Health
Medtronic
Cerilliant
Argus Health
Daiichi Sankyo
McKinsey
Covington
Harvard Business School

Generated: June 27, 2017

DrugPatentWatch Database Preview

PERSANTINE Drug Profile

« Back to Dashboard

Which patents cover Persantine, and what generic Persantine alternatives are available?

Persantine is a drug marketed by Boehringer Ingelheim and is included in one NDA.

The generic ingredient in PERSANTINE is dipyridamole. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.

Summary for Tradename: PERSANTINE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list95
Clinical Trials: see list6
Patent Applications: see list6,732
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PERSANTINE at DailyMed

Pharmacology for Tradename: PERSANTINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim
PERSANTINE
dipyridamole
TABLET;ORAL012836-003Dec 22, 1986ABRXYesNo► Subscribe► Subscribe
Boehringer Ingelheim
PERSANTINE
dipyridamole
TABLET;ORAL012836-004Feb 6, 1987ABRXYesNo► Subscribe► Subscribe
Boehringer Ingelheim
PERSANTINE
dipyridamole
TABLET;ORAL012836-005Feb 6, 1987ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Moodys
Express Scripts
Colorcon
Covington
Daiichi Sankyo
McKesson
Medtronic
US Department of Justice
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot